This is a preview of subscription content, log in via an institution to check access.
Reference
Martin-Pena A, et al. A cost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia. Antimicrobial Agents and Chemotherapy : 15 Jul 2013. Available from: URL: http://dx.doi.org/10.1128/AAC.00723-13
Rights and permissions
About this article
Cite this article
Diagnostic-driven antifungal therapy preferable in PFN. PharmacoEcon Outcomes News 683, 8 (2013). https://doi.org/10.1007/s40274-013-0578-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0578-0